Kiromic Biopharma Inc Stock Ownership - Who owns Kiromic Biopharma?

Insider buying vs selling

Have Kiromic Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KRBP insiders and whales buy or sell their stock.

KRBP Shareholders

What type of owners hold Kiromic Biopharma Inc stock?
Internati Maurizio Chiriva226.58%1,378,072$6.05MInsider
Pietro Bersani104.95%638,298$2.80MInsider
Sabby Management LLC90.42%549,944$2.41MInstitution
Scott Dahlbeck81.67%496,757$2.18MInsider
Tony Tontat66.09%402,000$1.76MInsider
Gianluca Rotino52.61%320,000$1.40MInsider
Zeke Capital Advisors LLC17.59%107,000$469.73kInstitution
Daniel Grant Clark10.32%62,770$275.56kInsider
Michael Charles Ryan8.25%50,189$220.33kInsider
Geode Capital Management LLC6.73%40,962$179.82kInstitution

1 of 3

KRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCBP1.15%98.85%Net Buying
NBY0.00%100.00%Net Selling
PALI0.00%100.00%Net Buying

Kiromic Biopharma Stock Ownership FAQ

Who owns Kiromic Biopharma?

Kiromic Biopharma (NASDAQ: KRBP) is owned by 132.45% institutional shareholders, 551.30% Kiromic Biopharma insiders, and 0.00% retail investors. Internati Maurizio Chiriva is the largest individual Kiromic Biopharma shareholder, owning 1.38M shares representing 226.58% of the company. Internati Maurizio Chiriva's Kiromic Biopharma shares are currently valued at $5.77M.

If you're new to stock investing, here's how to buy Kiromic Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.